Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 14/20 | 0.44 |
| ▸ | AKR1C2 | P52895 | 14/20 | 0.44 |
| ▸ | AKR1B10 | O60218 | 3/20 | 0.44 |
| ▸ | AKR1C4 | P17516 | 3/20 | 0.44 |
| ▸ | AKR1C1 | Q04828 | 3/20 | 0.44 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | AKT1 | P31749 | 3/20 | 0.39 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27613295 | 0.86 | AKR1C3 (0.45) | AKR1C3AKR1C2AKR1B10AKR1C4AKR1C1 | |
| SCHEMBL27821733 | 0.84 | AKR1C3 (0.44) | AKR1C3AKR1C2AKR1B10AKR1C4AKR1C1 | |
| SCHEMBL16464213 | 0.79 | PNMT (0.54) | — | |
| SCHEMBL27664126 | 0.76 | AKR1C3 (0.50) | AKR1C3AKR1C2AKR1C4AKR1C1 | |
| SCHEMBL27840752 | 0.75 | MPL (0.36) | NR3C2EPHX1AKT1SCN8A | |
| SCHEMBL2738398 | 0.74 | AKT1 (0.52) | AKR1C3AKR1C2AKR1B10AKR1C4AKR1C1 | |
| SCHEMBL680756 | 0.74 | AKT1 (0.47) | AKR1C3AKR1C2AKR1B10AKR1C4AKR1C1 | |
| SCHEMBL7292383 | 0.73 | EPHX1 (0.42) | AKR1C3AKR1C2AKR1B10AKR1C4AKR1C1 | |
| SCHEMBL27897775 | 0.73 | SCN8A (0.38) | AKR1C3AKR1C2AKR1B10AKR1C4AKR1C1 | |
| SCHEMBL2646312 | 0.73 | EPHX1 (0.51) | AKR1C3AKR1C2AKR1B10AKR1C4AKR1C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102209538-A | Combination therapy of P70S 6 kinase inhibitors and EGFR inhibitors | LILLY CO ELI | 2011-10-05 | — | — | CN | disclosed |
| CN-102209539-A | Combination therapy of P70S 6 kinase inhibitors and MTOR inhibitors | LILLY CO ELI | 2011-10-05 | — | — | CN | disclosed |